| Literature DB >> 30442908 |
Yasuto Narita1, Atsuhiro Tsutiya1, Yui Nakano1, Moe Ashitomi1, Kenjiro Sato1, Kohei Hosono2, Toyoji Kaneko2, Ruo-Dong Chen3, Jay-Ron Lee3, Yung-Che Tseng3, Pung-Pung Hwang3, Ritsuko Ohtani-Kaneko4.
Abstract
The neuroplastic mechanisms in the fish brain that underlie sex reversal remain unknown. Gonadotropin-releasing hormone 3 (GnRH3) neurons control male reproductive behaviours in Mozambique tilapia and show sexual dimorphism, with males having a greater number of GnRH3 neurons. Treatment with androgens such as 11-ketotestosterone (KT), but not 17β-estradiol, increases the number of GnRH3 neurons in mature females to a level similar to that observed in mature males. Compared with oestrogen, the effect of androgen on neurogenesis remains less clear. The present study examined the effects of 11-KT, a non-aromatizable androgen, on cellular proliferation, neurogenesis, generation of GnRH3 neurons and expression of cell cycle-related genes in mature females. The number of proliferating cell nuclear antigen-positive cells was increased by 11-KT. Simultaneous injection of bromodeoxyuridine and 11-KT significantly increased the number of newly-generated (newly-proliferated) neurons, but did not affect radial glial cells, and also resulted in newly-generated GnRH3 neurons. Transcriptome analysis showed that 11-KT modulates the expression of genes related to the cell cycle process. These findings suggest that tilapia could serve as a good animal model to elucidate the effects of androgen on adult neurogenesis and the mechanisms for sex reversal in the fish brain.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30442908 PMCID: PMC6237963 DOI: 10.1038/s41598-018-35303-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1PCNA immunostaining in the female tilapia brain. (a) Left: Representative frontal section of the female tilapia brain crossing the terminal nerve (TN) immunostained with PCNA antibody. The two inserted squares correspond to regions in the dorsal and ventral areas used for counting cells displaying a PCNA-positive nucleus (each area, 140 µm × 140 µm) around the ventricle. Arrows indicate PCNA-positive cells. Right: Atlas of the brain corresponding to the left image. Dm = medial zone of dorsal telencephalic area; Dd = dorsal zone of dorsal telencephalic area; Dl = lateral zone of dorsal telencephalic area; Vd = dorsal nucleus of ventral telencephalic area; Vv, = ventral nucleus of ventral telencephalic area; v = ventricle. (b) Representative image of PCNA-positive cells in the dorsal and ventral areas around the ventricle at the level of the TN in 11-KT-treated and control (Cont) female tilapia. Arrows indicate PCNA-positive nuclei. (c) Density of PCNA-positive cells in control and 11-KT-treated females in the dorsal and ventral areas around the ventricle. **Indicates p < 0. 01 (unpaired Student’s t-test). Data are expressed as mean ± SEM.
Figure 2Representative images obtained from double immunohistochemistry with BrdU and Hu antibodies. (a) Hu-positive cells (red) observed in dorsal and ventral areas around the ventricle in control (cont) and 11-KT-treated (11-KT) females (A,B,C,D). Although few BrdU-labelled nuclei (green) were detected in control animals (E,G), BrdU-labelled nuclei were frequently observed in 11-KT-treated females (F,H). I,J,K and L show merged images. Ia,b,Ja,b,Ka,b and La,b show enlarged images of the areas inset in I,J,K, and L, respectively; v = ventricle. (b) The number of Hu-positive cells with a BrdU-labelled nucleus. White and black bars indicate the numbers of double-labelled cells in control (Cont) and 11-KT-treated (11-KT) females. **Indicates p < 0. 01; ***Indicates p < 0. 001 (unpaired Student’s t-test). Data are expressed as mean ± SEM.
Figure 3Representative merged images of sections double-stained with BrdU and GFAP antibodies. GFAP-positive cells (red) visualized on the inner surface of the ventricle, with long processes in the dorsal and ventral areas around the ventricle in control (Cont) and 11-KT-treated (11-KT) females. (A,B) dorsal and ventral areas, respectively, of control animals. (C,D) dorsal and ventral areas, respectively, of 11-KT-treated females. A’,B’,C’ and D’ show enlarged views of inset squares in A,B,C, and D, respectively; v = ventricle.
Figure 4Representative images of sections double-stained with BrdU and GnRH3 antibodies. (a) GnRH3 neurons (red), BrdU-labelling nuclei (green) and merged images in control (Cont) and 11-KT treated (11-KT) females. GnRH3 neurons with BrdU-labelling in the nucleus were observed in 11-KT treated females, but not in controls. The rightmost column shows enlarged views of inserted squares in the second from the right column. (b) Number of GnRH3 neurons in control (Cont, white column) and 11-KT-treated (11-KT, black column) females (left) three days after 11-KT injection. Number of double labelled cells (GnRH & BrdU) in control (Cont, white column) and 11-KT treated (11-KT, black column) animals (right); N. D. = not detected. (c) Relative expression levels of GnRH3 mRNA in control (Cont, white column) and 11-KT treated (11-KT, black column) females one day (left) and three days (right) after 11-KT injection. **Indicates p < 0.01; ***Indicates p < 0.001 (unpaired Student’s t-test). Data are expressed as mean ± SEM.
Cell cycle related gene expressions which were affected by 11-KT.
| Gene Symbol | Gene Name | Accession No. | Fold Change | Function | |
|---|---|---|---|---|---|
|
| polyubiquitin | XM_019365938 | 11.17 | ubiquitin gene, Ubiquitination has been associated with protein degradation, DNA repair, cell cycle regulation, kinase modification, endocytosis, and regulation of other cell signaling pathways. | |
|
| cyclin B3 | XM_005458602 | 1.586 | Regulator of cyclin dependent kinase | |
|
| cyclin E2 | XM_005472790 | 1.567 | Regulator of cyclin dependent kinase | |
|
| cyclin B2 | XM_005457408 | 1.541 | Regulator of cyclin dependent kinase.The B-type cyclins, B1 and B2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery | |
|
| retinoblastoma-like protein 2 | XM_019360388 | 1.464 | Key regulator of entry into cell division | |
|
| transcription factor E2F2 | XM_003453243 | 1.422 | The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. | |
|
| cell division control protein 7 | XM_005476033 | 1.321 | ATP binding, kinase activity, metal ion binding, protein binding, protein kinase activity, protein serine/threonine kinase activity | |
|
| CDC28 protein kinase regulatory subunit 1B | XM_003452448 | 1.234 | cyclin-dependent protein serine/threonine kinase activator activity, histone binding, protein binding, protein kinase binding, ubiquitin binding | |
|
|
| activator of S phase kinase | XM_003450951 | 1.204 | Regulatory subunit for CDC7 which activates its kinase activity thereby playing a central role in DNA replication and cell proliferation. |
|
| origin recognition complex subunit 3 | XM_003453228 | −1.211 | DNA replication origin binding, protein binding | |
|
| cyclin B1 | XM_003440084 | −1.223 | Regulator of cyclin dependent kinase.The B-type cyclins, B1 and B2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery | |
|
| protein phosphatase 2 regulatory subunit B’gamma | XM_003440783 | −1.257 | Phosphatase 2 A regulatory subunit B family. It is implicated in the negative control of cell growth and division. | |
|
| cyclin A1 | XM_003458268 | −1.335 | Regulator of cyclin dependent kinase | |
|
|
| F-box and leucine-rich repeat protein 1 (S-phase kinase-associated protein 2) | XM_005449432 | −1.557 | SKP2 has been implicated in double negative feedback loops with both p21 and p27, that control cell cycle entry and G1/S transition |
|
| cyclin D2 | XM_003442521 | −1.941 | Regulator of cyclin dependent kinase | |
|
| cell division control protein 6 | XM_003454088 | −2.878 | ATP binding, kinase binding, nucleotide binding, protein binding | |
|
| cyclin-E3 | XM_019351010 | −4.291 | Regulator of cyclin dependent kinase | |
|
| cyclin-dependent kinase inhibitor 2 C | XM_019351452 | −1000 | cyclin-dependent protein serine/threonine kinase inhibitor activity | |
|
|
| cohesin complex componet | XM_003447160 | −1000 | The RAD21 gene provides instructions for making a protein that is involved in regulating the structure and organization of chromosomes during cell division. |
The table provides a description that includes the gene symbol, name and function for each gene affected by 11-KT treatment. It also gives the fold change (11-KT/control) for each gene that was affected by 11-KT treatment.
Figure 5Changes in expressions of genes related to cell cycle after 11-KT treatment. Expressions of 19 genes listed in Table 1 were examined by real-time RT-qPCR analysis and compared between control (white column) and 11-KT treated (11-KT, black column) females. The numeric values on the top of each graph indicates the fold change as revealed by the transcriptome analysis. *Indicates p < 0. 05, **Indicates p < 0.01 (unpaired Student’s t-test). Data are expressed as mean ± SEM.
Figure 6Cell cycle regulation pathway and the genes whose expressions were altered by 11-KT. The figure was slightly modified from ‘Cell cycle’ pathway (map04110, KEGG). Genes whose expressions were increased (red, fold change >1. 2) or decreased (blue, fold change < -1. 2) by 11-KT treatment were marked in the figure. Ubc coding polyubiquitin-C precursor regulates each phase of the cell cycle through the degradation of cyclins.